Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

A Multi-National Mega Corp Trialled The 4-Day Work Week Got Great Results So Let’s Goooo

If even Unilever, of all companies, is allowing its staff a 4 day work week then we know that shit works.

Pedestrian.tv

CSL paying $312m to license mRNA vax tech

CSL Seqirus is paying $A312 million up-front to license next-generation mRNA technology from a small US company, Arcturus Therapeutics.

AAP

Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study

Gb Sciences, Inc. (OTCQB: GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, co-published a study that demonstrates the potential of selected cannabinoids and terpenes to reduce inflammation.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Ketamine Could Soon Be A Treatment Option For This Rare Genetic Neurological Disorder

Specialty biopharma company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has entered into an evaluation and exclusive option agreement with Case Western Reserve University (CWRU)

Benzinga

After Prime Medicine, What's the Next Gene Editing IPO?

Three privately-held biotech companies could be next in line for making the jump to public markets.

The Street

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know

Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application.

Benzinga

The Worst Biotech Stocks Investors Could Buy This Fall

Timber Pharmaceuticals (TMBR) recently received an NYSE warning for not meeting the minimum trading price requirement for quite some time. The stock has lost 84% year-to-date. Given the company’s weak fundamentals, the stock could be a poor choice for investors enticed by its negligible price. Let’s discuss….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Australian workers to trial four-day week

Consumer goods giant Unilever is expanding its four-day work week trial to Australia after impressive results in New Zealand.

AAP

How coal miners and factory workers helped found the environmental movement

Rachel Carson, a scientist and writer from rural Pennsylvania, published Silent Spring 60 years ago. Many credit this book, which meticulously documented the damage that DDT pesticides were inflicting on wildlife, farm animals and people as early as the 1950s, with launching the modern environmental movement.

The Conversation

Why IBD 50 Stock Harmony Biosciences Surged Well Above A Buy Zone

Harmony crushed third-quarter forecasts and unveiled promising results for its narcolepsy drug — leading the biotech stock to surge Tuesday.

Investors Business Daily

The Three Pillars of Effective Ketamine Mental Health Treatment

By Kevin Nicholson, COO of Delic and CEO of Ketamine Wellness Centers

Benzinga

Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More

15 Global Psychedelics Executives To Keep An Eye On In 2022

Benzinga

Ask an Immunity Expert: What’s Next for COVID-19?

This pandemic can help us prepare for the next one, says Catherine Hankins, co-chair of Canada’s COVID-19 Immunity Task Force

The Walrus

Blazing Hot Neurocrine Biosciences, With 40% Run This Year, Extends Breakout On Quarterly Beat

Neurocrine Biosciences beat third-quarter forecasts and raised its Ingrezza outlook for 2022, leading NBIX stock to jump Tuesday.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Pfizer Hits Trifecta, Boosting Guidance After Quarterly Beat And Unveiling A Potential Win

Pfizer stock surged Tuesday after the company beat quarterly estimates, raised its outlook and announced respiratory vaccine data.

Investors Business Daily

Why Eli Lilly's Third-Quarter Beat Wasn't Enough To Save Its Outlook

Eli Lilly topped third-quarter expectations Thursday, but cut its 2022 outlook, citing exchange rates and tax law. LLY stock tumbled.

The Street

Abiomed Stock Soars After $16.6 Billion Johnson & Johnson Takeover Amid Deeper Medical Devices Push

"The addition of Abiomed is an important step in our vision for the new Johnson & Johnson focused on Pharmaceutical and MedTech," said CEO Joaquin Duato.

AFP

Pfizer lifts 2022 forecast for Covid-19 vaccine sales as profits rise

New York (AFP) - Pfizer reported higher quarterly profits Tuesday as it lifted its full-year forecast for coronavirus vaccine sales and predicted Covid-19 would yield billions more in revenues for the forseeable future.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Eli Lilly Stock Slides As Muted 2022 Outlook Offsets Q3 Earnings Beat

A surging U.S. dollar and increasing generic competition combined for another disappointing outlook for drugmaker Eli Lilly, offsetting stronger-than-expected third quarter earnings.

Investors Business Daily

Dow Jones Reverses Lower After Key Economic Data; Pfizer, Uber Jump On Earnings

The Dow Jones Industrial Average reversed lower Tuesday after key economic data. Pfizer and Uber jumped on earnings results.

The Independent UK

Indonesia revokes drug companies' licenses after 159 deaths

Indonesian authorities have revoked the licenses of two pharmaceutical companies to produce syrup-type medicines following the deaths of 159 children due to acute kidney injury

The Street

Pfizer Stock Leaps As Covid Vaccine Sales Power Q3 Earnings Beat, Profit Forecast Boost

"Our COVID-19 franchises will remain multi-billion-dollar revenue generators for the foreseeable future," said CEO Albert Bourla.

The Independent UK

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

1 … 101 102 103 104

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.